Viewing Study NCT00411593

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2025-12-27 @ 1:39 AM
Study NCT ID: NCT00411593
Status: WITHDRAWN
Last Update Posted: 2012-02-08
First Post: 2006-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Small Cell Lung Cancer View
None Lung Cancer View
None NSCLC View
None Bortezomib View
None Bevacizumab View